Signify Health, Inc.
SGFY · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $806 | $773 | $611 | $502 |
| % Growth | 4.2% | 26.7% | 21.7% | – |
| Cost of Goods Sold | $440 | $394 | $307 | $247 |
| Gross Profit | $365 | $380 | $304 | $255 |
| % Margin | 45.3% | 49.1% | 49.8% | 50.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $202 | $245 | $208 | $169 |
| Sales & Mktg Exp. | $0 | $0 | $208 | $169 |
| Other Operating Expenses | $54 | $71 | $62 | $66 |
| Operating Expenses | $256 | $315 | $270 | $235 |
| Operating Income | $109 | $62 | $25 | $22 |
| % Margin | 13.5% | 8% | 4% | 4.3% |
| Other Income/Exp. Net | -$246 | -$30 | -$31 | -$50 |
| Pre-Tax Income | -$137 | $14 | -$14 | -$28 |
| Tax Expense | -$6 | $4 | $1 | $0 |
| Net Income | -$130 | $10 | -$15 | -$29 |
| % Margin | -16.2% | 1.3% | -2.4% | -5.7% |
| EPS | -0.74 | 0.058 | -0.087 | -0.17 |
| % Growth | -1,387% | 165.8% | 48.6% | – |
| EPS Diluted | -0.74 | 0.058 | -0.087 | -0.17 |
| Weighted Avg Shares Out | 176 | 169 | 166 | 164 |
| Weighted Avg Shares Out Dil | 176 | 172 | 166 | 164 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $21 | $22 | $22 | $21 |
| Depreciation & Amortization | -$137 | $71 | $62 | $66 |
| EBITDA | -$28 | $133 | $87 | $82 |
| % Margin | -3.4% | 17.1% | 14.2% | 16.3% |